Coles’ 1Q27 update and earnings downgrade disappointed the market with management outlining its strategic pathway to arrest the market share declines
This story analyses criminal proceedings involving unlisted capital raisings, witness tampering charges, adviser tribunal bans, and asset preservation orders
RedMed posted a stronger than expected first quarter, although various contingencies were reflected in the result and the subsequent outlook
Woolworths management has made considerable headway in improving its offering to consumers, as reflected in a robust 1Q27 result, but analysts are questioning whether the momentum can be sustained
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
BlueScope Steel’s earnings upgrade highlights its exposure to a tightening US steel market, raising hopes for greater shareholder returns
The Federal Court has ordered Hollard Insurance to pay a $2 million penalty over delays in handling a home insurance claim, putting claims handling firmly in the regulatory spotlight
Sigma Healthcare is expanding at home and abroad, with oral GLP-1 medicines offering further upside
The global AI infrastructure boom is colliding with real-world constraints, forcing NextDC to issue a shock profit warning last week
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements